Search Results - "Genovesi, Eugene V."
-
1
Orally Active Fusion Inhibitor of Respiratory Syncytial Virus
Published in Antimicrobial Agents and Chemotherapy (01-02-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
2
Long-Term Entecavir Treatment Results in Sustained Antiviral Efficacy and Prolonged Life Span in the Woodchuck Model of Chronic Hepatitis Infection
Published in The Journal of infectious diseases (15-11-2001)“…Entecavir (ETV) is a guanosine nucleoside analogue with potent antiviral efficacy in woodchucks chronically infected with woodchuck hepatitis virus. To explore…”
Get full text
Journal Article -
3
Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection
Published in Antimicrobial Agents and Chemotherapy (01-07-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
4
Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo
Published in Bioorganic & medicinal chemistry letters (15-08-2009)“…A series of bezimidazole-isatin oximes were prepared and profiled as inhibitors of respiratory syncytial virus (RSV) replication in cell culture…”
Get full text
Journal Article -
5
Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability
Published in Bioorganic & medicinal chemistry letters (15-02-2007)“…A series of benzimidazole-based inhibitors of respiratory syncytial virus (RSV) fusion were optimized for antiviral potency, membrane permeability and…”
Get full text
Journal Article -
6
Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety
Published in Bioorganic & medicinal chemistry letters (01-09-2007)“…The effect of structural variation of the benzimidazol-2-one ring of RSV fusion inhibitors related to BMS-433771 ( 1) was examined in conjunction with side…”
Get full text
Journal Article -
7
Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo
Published in Bioorganic & medicinal chemistry letters (01-03-2006)“…The introduction of acidic and basic functionality into the side chains R and R′ of respiratory syncytial virus (RSV) fusion inhibitors 2 was examined in an…”
Get full text
Journal Article -
8
Adoptive transfer of antiviral resistance by lymphoid cells from mice protected against Friend leukemia virus-induced disease by passive serum therapy
Published in Cancer research (Chicago, Ill.) (01-06-1981)“…Spleen and bone marrow cells from DBA/2 mice protected against infection with a leukemogenic dose of Friend leukemia virus (FLV) by passive therapy with…”
Get full text
Journal Article -
9
Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy
Published in Cancer research (Chicago, Ill.) (01-04-1984)“…Previous studies have demonstrated that spleen cells from DBA/2 mice protected against challenge with a leukemogenic dose of Friend leukemia virus (FLV) by…”
Get full text
Journal Article -
10
Susceptibility of Friend Virus Antigen-Modulated Erythroleukemic Cells to Lysis by T Lymphocytes from Mice with Dormant Friend Virus Infections
Published in The Journal of immunology (1950) (01-03-1979)“…Spleen cells from DBA/2 mice with dormant Friend leukemia virus (FLV) infections or from mice immunized with x-irradiated FLC-745 erythroleukemic cells are not…”
Get full text
Journal Article -
11
-
12
Orally active fusion inhibitor of respiratory syncytial virus
Published in Antimicrobial agents and chemotherapy (2004)Get full text
Journal Article -
13
In vivo and in vitro effects of moderately virulent African swine fever virus on mitogenesis of pig lymphocytes
Published in Veterinary immunology and immunopathology (01-07-1987)“…Six pigs were infected oro-nasally with a moderately virulent African swine fever (ASF) virus from the Dominican Republic (DR II). The effect of virus…”
Get more information
Journal Article -
14
Susceptibility of inbred Syrian golden hamsters (Mesocricetus auratus) to lethal disease by lymphocytic choriomeningitis virus
Published in Proceedings of the Society for Experimental Biology and Medicine (01-07-1987)“…An acutely lethal LCMV disease model has been established in the Syrian golden hamster (Mesocricetus auratus) in which lethality and disease are dependent upon…”
Get more information
Journal Article -
15
Immunotherapy of murine leukemia. VII. Prevention of Friend leukemia virus-induced immunosuppression by passive serum therapy
Published in International journal of cancer (15-11-1982)“…Previous studies have suggested that the passive therapy of Friend leukemia virus (FLV)-induced disease with chimpanzee anti-FLV serum operates by reducing the…”
Get more information
Journal Article -
16
Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy
Published in JNCI : Journal of the National Cancer Institute (01-09-1981)“…The development of immune complex glomerulonephritis in DBA/2 mice infected with Friend murine leukemia virus (F-MuLV) was compared with that in mice protected…”
Get more information
Journal Article -
17
In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus
Published in Journal of cellular physiology (01-11-1983)“…An in vitro complement (C')-independent growth cytostasis model is described in which the replication of Friend leukemia virus (FLV)-induced erythroleukemia…”
Get more information
Journal Article -
18
Immunotherapy of murine leukemia VI. Development of immunologic memory in mice protected against Friend leukemia virus-induced disease by passive serum therapy
Published in Leukemia research (1982)“…The resistance of DBA/2 mice to infection with a leukemogenic dose of Friend leukemia virus (FLV) as a result of the passive administration of chimpanzee…”
Get more information
Journal Article -
19
Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice
Published in JNCI : Journal of the National Cancer Institute (01-02-1983)“…Previous studies have demonstrated that the passive therapy of Friend murine leukemia virus (F-MuLV)-induced disease with chimpanzee anti-F-MuLV serum is…”
Get more information
Journal Article -
20
Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia
Published in The Journal of experimental medicine (01-08-1977)“…Friend leukemia virus (FLV) erythroleukemic cells cultured in medium containing FLV-immune serum from dormant FLV-infected mice undergo modulation of FLV cell…”
Get full text
Journal Article